To better understand the molecular mechanisms involved, Valiente et al. reported that plasminogen activator inhibitors (SerpinB2 and Neuroserpin) protect cancer cells from an apoptotic cascade initiated by the formation of plasmin in the brain stroma, and along with L1CAM, they are crucial for protecting cancer cells and promoting vascular co-option [6]. Here, PLG is linked to cancer.